Project Grant R21AT013164
Award Date
9/17/24
Completion Date
8/31/26
Dollars Obligated
$356K
Federal Agency
National Center for Complementary and Integrative Health
Federal Grant Program
93.213
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40536, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,510,066 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to The University of Kentucky Research Foundation to conduct a planning study for the development of sigma 2 ligands as novel analgesics for chronic neuropathic pain. The funding will support an interdisciplinary research team to: (1) develop an in-silico library of potential sigma 2 ligand analogs, (2) synthesize and evaluate...
This $433,710 federal Project Grant award was provided by the National Institutes of Health's National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award aims to fund complementary and integrative research on the unique and overlapping mechanisms of action of cannabis and kratom constituents, as well as their potential synergistic effects, in mouse models of neuropathic pain,...
The University of Kentucky Research Foundation was awarded a $1,376,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) on September 15, 2022. The grant will fund the development of a highly selective MPGES-1 inhibitor as a non-opioid treatment for chronic pain through September 14, 2026. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health federal grant program (CFDA 93.213), is providing $242,310 to the University of Illinois to conduct research on Aristotelia alkaloids as probes for the nicotinic acetylcholine receptors. The research aims to extract and isolate Aristotelia alkaloids, evaluate their activity and mechanism of action at multiple nicotinic...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under CFDA 93.213 - Research and Training in Complementary and Integrative Health provides $451,000.00 in funding to The Trustees of Princeton University from September 2024 to August 2026. The objective is to characterize the secondary metabolomes of three Corynebacterial strains, including uncovering the small molecule products they use to compete with other microbes and interact with host cells....
The National Center for Complementary and Integrative Health (NCCIH) awarded a $135,317 Project Grant under the Research and Training in Complementary and Integrative Health (CFDA 93.213) program to Portland State University. The grant supports the development of a culturally and structurally adapted Chronic Pain Self-Management Program (CPSMP) for young Black adults. The goal is to determine the clinical characteristics, comorbidities, and treatments used by this population, identify their...
The National Center for Complementary and Integrative Health (NCCIH), a component of the National Institutes of Health (NIH), awarded a $817,330 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to the University of Virginia. The grant will fund a 5-year study to investigate adding a positive affect enhancing intervention (savoring meditation) as an adjunct to cognitive behavioral therapy for insomnia (CBTI) to improve pain outcomes for...
This Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $5,000 to the University of California, San Diego to discover novel natural products that are potent blood-brain barrier (BBB) permeable inhibitors of the enzyme cathepsin L. The goal is to identify a lead drug candidate that can reduce spinal dynorphin and alleviate chronic pain without the risk of addiction, which is a...
The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.395 - Cancer Treatment Research) to the University of Nebraska Medical Center (UNMC) worth $179,403 from April 1, 2025 to March 31, 2027. The grant supports the synthesis and screening of flupirtine analogue compounds to develop a new non-opioid, non-steroidal analgesic for the treatment of chemotherapy-induced neuropathic pain (CINP). Specifically, the project aims to (1) develop potent KV7.2/7.3 activators with improved liver...
The University of North Carolina at Charlotte received a three-year, $892,728 Project Grant from the National Center for Complementary and Integrative Health within the Department of Health and Human Services National Institutes of Health. The grant supports research under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), which evaluates complementary and integrative health approaches. Specifically, the grant will fund research from August 1, 2022 to July...